CELLGENTECH INC has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and agriculture are TAN JUN, KB BIOMED INC and RATH MATTHIAS W.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Japan | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Agriculture | |
#4 | Biotechnology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Animal care | |
#5 | Enzymes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Suzumiya Junji | 8 |
#2 | Jimi Shiro | 8 |
#3 | Sato Tomohito | 4 |
#4 | Waki Atsuo | 3 |
#5 | Aso Masayoshi | 2 |
#6 | Fukuchi Junichi | 2 |
#7 | Aso Masayuki | 2 |
#8 | Kuroda Masayuki | 1 |
#9 | Asada Sakiyo | 1 |
#10 | Bujo Hideaki | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011090091A1 | Method for determination whether or not cell population is suitable for foreign gene transfer for the purpose of preparation of adipocytes for gene therapy application | |
WO2008108344A1 | Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell | |
JP2009179571A | Agent for reinforcing wound-treating effect of g-csf by external application | |
US2010137190A1 | Liquid composition for external application and preparation for external application for treatment of skin ulcer | |
EP1803464A1 | External preparation for treating skin ulcer |